Christopher Adams

Mr. Christopher Adams


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
CAChristopher Adams
Christopher Adams
ARAhmad Rai
Ahmad Rai
GSGregor Sneddon
Gregor Sneddon
HYHumphrey H.P. Yiu
Humphrey H.P. Yiu
BPBoris Polyak
Boris Polyak
DCDivya Chari
Divya Chari

11 February 2016 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
PDF file
CAChristopher Adams
Christopher Adams
LILiron L Israel
Liron L Israel
SOStella Ostrovsky
Stella Ostrovsky
ATArthur Taylor
Arthur Taylor
HPHarish Poptani
Harish Poptani
DCDivya Chari
Divya Chari

22 February 2022 in Frontiers in Medical Technology
Verified
Journal Article
Open access
AMAnthea R. Mutepfa
Anthea R. Mutepfa
John HardyJohn Hardy
John Hardy
CAChristopher Adams
Christopher Adams
Spinal cord injury (SCI) is a serious condition caused by damage to the spinal cord through trauma or disease, often with permanent debilitating effects. Globally, the prevalence of SCI is estimated between 40 to 80 cases per million people per year. Patients with SCI can experience devastating health and socioeconomic consequences from paralysis, which is a loss of motor, sensory and autonomic nerve function below the level of the injury that often accompanies SCI. SCI carries a high mortality and increased risk of premature death due to secondary complications. The health, social and economic consequences of SCI are significant, and therefore elucidation of the complex molecular processes that occur in SCI and development of novel effective treatments is critical. Despite advances in medicine for the SCI patient such as surgery and anaesthesiology, imaging, rehabilitation and drug discovery, there have been no definitive findings toward complete functional neurologic recovery. However, the advent of neural stem cell therapy and the engineering of functionalized biomaterials to facilitate cell transplantation and promote regeneration of damaged spinal cord tissue presents a potential avenue to advance SCI research. This review will explore this emerging field and identify new lines of research.

Verified
Journal Article
Open access
PDF file
MPMark Pickard
Mark Pickard
CAChristopher Adams
Christopher Adams
PBPerrine Barraud
Perrine Barraud
DCDivya Chari
Divya Chari
Genetically engineered neural stem cell (NSC) transplants offer a key strategy to augment neural repair by releasing therapeutic biomolecules into injury sites. Genetic modification of NSCs is heavily reliant on viral vectors but cytotoxic effects have prompted development of non-viral alternatives, such as magnetic nanoparticle (MNPs). NSCs are propagated in laboratories as either 3-D suspension “neurospheres” or 2-D adherent “monolayers”. MNPs deployed with oscillating magnetic fields (“magnetofection technology”) mediate effective gene transfer to neurospheres but the efficacy of this approach for monolayers is unknown. It is important to address this issue as oscillating magnetic fields dramatically enhance MNP-based transfection in transplant cells (e.g., astrocytes and oligodendrocyte precursors) propagated as monolayers. We report for the first time that oscillating magnetic fields enhanced MNP-based transfection with reporter and functional (basic fibroblast growth factor; FGF2) genes in monolayer cultures yielding high transfection versus neurospheres. Transfected NSCs showed high viability and could re-form neurospheres, which is important as neurospheres yield higher post-transplantation viability versus monolayer cells. Our results demonstrate that the combination of oscillating magnetic fields and a monolayer format yields the highest efficacy for MNP-mediated gene transfer to NSCs, offering a viable non-viral alternative for genetic modification of this important neural cell transplant population.

28 September 2016 in Nanoscale
Verified
Journal Article
Closed access
PDF file
CAChristopher Adams
Christopher Adams
ADAndrew W. Dickson
Andrew W. Dickson
JKJan-Herman Kuiper
Jan-Herman Kuiper
DCDivya Chari
Divya Chari
We demonstrate bioengineering of neural stem cells grown in physiologically relevant, neuromimetic hydrogels using magnetofection (translatable genetic engineering).

2 February 2017 in Current Protocols in Stem Cell Biology
Verified
Journal Article
Open access
PDF file
MPMark R. Pickard
Mark R. Pickard
CAChristopher Adams
Christopher Adams
DCDivya Chari
Divya Chari
Neural stem cells (NSCs) have high translational potential in transplantation therapies for neural repair. Enhancement of their therapeutic capacity by genetic engineering is an important goal for regenerative neurology. Magnetic nanoparticles (MNPs) are major non-viral vectors for safe bioengineering of NSCs, offering critical translational benefits over viral vectors, including safety, scalability, and ease of use. This unit describes protocols for the production of suspension (neurosphere) and adherent (monolayer) murine NSC cultures. Genetic engineering of NSCs with MNPs and the application of ‘magnetofection’ (magnetic fields) or ‘multifection’ (repeat transfection) approaches to enhance gene delivery are described. Magnetofection of monolayer cultures achieves optimal transfection, but neurospheres offer key advantages for neural graft survival post-transplantation. A protocol is presented which allows the advantageous features of each approach to be combined into a single procedure for transplantation. The adaptation of these protocols for other MNP preparations is considered, with emphasis on the evaluation of procedural safety. © 2017 by John Wiley & Sons, Inc.